InterMune Canada has announced the availability of idiopathic pulmonary fibrosis (IPF) therapy, Esbriet, in Canada. University of Toronto professor and vice-chair of medicine and University Health Network IPF researcher and consultant ...
Tags: fibrosis therapy, InterMune, medicine
InterMune has completed divestiture of Actimmune (interferon gamma-1b) to Vidara Therapeutics, a part of an international specialty pharmaceutical group of companies with operations in Ireland and the US. Gross proceeds from the sale ...
Tags: Actimmune, interferon gamma-1b, esbriet, pirfenidone
InterMune has signed a definitive agreement with Vidara Therapeutics International (Vidara) to sell its rights to Actimmune (interferon gamma-1b) in $55m cash transaction and a two-year royalty stream. Actimmune, a synthesized version of ...
Tags: Actimmune, interferon gamma-1b, Vidara, InterMune